Two new artificial intelligence products that can improve cardiac care

Certainly! Here are four key points from the article:

AI Tool for EKG Analysis: A new AI algorithm called EchoNext, developed by New York Presbyterian Hospital and Columbia University, is set to be available for clinicians through the OpenEvidence platform. This tool analyzes electrocardiograms (EKGs) to detect signs of structural heart disease, such as valve problems or heart failure.
Performance in Diagnosis: Research published in Nature Medicine found that EchoNext outperformed cardiologists in identifying structural heart disease across a standardized EKG dataset, demonstrating its potential to improve diagnostic accuracy.
Biomarker for Implantable Defibrillators: Another study in Nature employed deep learning to identify a biomarker that can more accurately determine which heart failure patients need implantable defibrillators (ICDs) to prevent sudden cardiac death.
Cost Implications: While these AI tools show promise in improving cardiac diagnosis and ensuring that the right patients receive follow-up tests or procedures, they are expected to raise healthcare costs due to increased utilization of expensive interventions.